149 related articles for article (PubMed ID: 34019363)
1. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia.
Sypek MP; Kausman JY; Watson N; Wyburn K; Holt SG; Hughes P; Clayton PA
Transplantation; 2021 Jun; 105(6):1317-1325. PubMed ID: 34019363
[TBL] [Abstract][Full Text] [Related]
2. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
3. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.
Shen SW; Chang CK; Gao YS; Hsu PJ; Cheng SC; Liu FY; Lo SC
J Formos Med Assoc; 2017 Dec; 116(12):956-963. PubMed ID: 29037453
[TBL] [Abstract][Full Text] [Related]
4. Calculated panel reactive antibody with decimals: A refined metric of access to transplantation for highly sensitized candidates.
Kransdorf EP; Pando MJ
Hum Immunol; 2017 Mar; 78(3):252-256. PubMed ID: 28069404
[TBL] [Abstract][Full Text] [Related]
5. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates.
Cecka JM
Am J Transplant; 2010 Jan; 10(1):26-9. PubMed ID: 19958328
[TBL] [Abstract][Full Text] [Related]
6. A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.
Chan YP; Wong MWK; Tang LWM; Guo M; Yang W; Ip P; Li PKT; Leung CB; Chau KF; Lam JCK; Yeung NKM; Kwok JSY
Transpl Int; 2017 Dec; 30(12):1234-1242. PubMed ID: 28777478
[TBL] [Abstract][Full Text] [Related]
7. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
[TBL] [Abstract][Full Text] [Related]
8. The calculated panel reactive antibody policy: an advancement improving organ allocation.
Leffell MS
Curr Opin Organ Transplant; 2011 Aug; 16(4):404-9. PubMed ID: 21666476
[TBL] [Abstract][Full Text] [Related]
9. Increased access to transplantation of highly sensitized patients under the new kidney allocation system. A single center experience.
Colovai AI; Ajaimy M; Kamal LG; Masiakos P; Chan S; Savchik C; Lubetzky M; de Boccardo G; Courson A; Chokechanachaisakul A; Graham J; Greenstein S; Kinkhabwala M; Rocca J; Akalin E
Hum Immunol; 2017 Mar; 78(3):257-262. PubMed ID: 27955974
[TBL] [Abstract][Full Text] [Related]
10. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
[TBL] [Abstract][Full Text] [Related]
11. The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.
Jackson KR; Covarrubias K; Holscher CM; Luo X; Chen J; Massie AB; Desai N; Brennan DC; Segev DL; Garonzik-Wang J
Am J Transplant; 2019 Apr; 19(4):1129-1138. PubMed ID: 30372592
[TBL] [Abstract][Full Text] [Related]
12. Low transplantability of 0 blood group and highly sensitized candidates in the Portuguese kidney allocation algorithm: quantifying an old problem in search of new solutions.
Tafulo S; Malheiro J; Dias L; Mendes C; Osório E; Martins LS; Santos J; Pedroso S; Almeida M; Castro-Henriques A
HLA; 2016 Nov; 88(5):232-238. PubMed ID: 27647555
[TBL] [Abstract][Full Text] [Related]
13. Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.
Karadeniz ST; Akgul SU; Ogret Y; Ciftci HS; Bayraktar A; Bakkaloglu H; Caliskan Y; Yelekci K; Turkmen A; Aydin AE; Oguz FS; Carin M; Aydin F
Transplant Proc; 2017 Apr; 49(3):445-447. PubMed ID: 28340809
[TBL] [Abstract][Full Text] [Related]
14. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.
Cecka JM; Kucheryavaya AY; Reinsmoen NL; Leffell MS
Am J Transplant; 2011 Apr; 11(4):719-24. PubMed ID: 21114658
[TBL] [Abstract][Full Text] [Related]
15. Stem cell donor HLA typing improves CPRA in kidney allocation.
Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X; Maiers M; Kobashigawa JA; Gragert L
Am J Transplant; 2021 Jan; 21(1):138-147. PubMed ID: 32558252
[TBL] [Abstract][Full Text] [Related]
16. Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list.
Kransdorf EP; Kittleson MM; Patel JK; Pando MJ; Steidley DE; Kobashigawa JA
J Heart Lung Transplant; 2017 Jul; 36(7):787-796. PubMed ID: 28318744
[TBL] [Abstract][Full Text] [Related]
17. Application of calculated panel reactive antibody using HLA frequencies in Koreans.
Jang JY; Kim YJ; Kim Y; Park YJ; Han K; Oh EJ
Ann Lab Med; 2012 Jan; 32(1):66-72. PubMed ID: 22259781
[TBL] [Abstract][Full Text] [Related]
18. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
Front Immunol; 2021; 12():687254. PubMed ID: 34248971
[TBL] [Abstract][Full Text] [Related]
19. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
[TBL] [Abstract][Full Text] [Related]
20. [Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation].
Luo M; Yu L; Xiao L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):477-81. PubMed ID: 24752091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
